Navegar por autor "Pérez de Llano, Luis"

Asma corticodependiente: nuestra experiencia clínica

2015- Pallarés Sanmartín, Abel; Golpe Gómez, Rafael; Pérez de Llano, Luis; Mengual Macenlle, Noemi

Central thromboembolism as a predictor of right ventricle dysfunction in hemodynamically stable pulmonary embolism

2011- Golpe Gómez, Rafael; Pérez de Llano, Luis

Clinical differences between patients with COPD due to biomass smoke or tobacco

2014- Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Sanjuan López, María del Pilar; Cano Jiménez, Esteban Alberto [et al.]

Cost-effectiveness of asthma management in a hospital-based adult asthma clinic in Spain

2014- Pérez de Llano, Luis

Distribución de fenotipos clínicos en pacientes con enfermedad pulmonar obstructiva crónica por humo de biomasa y por tabaco

2014- Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Sanjuan López, María del Pilar; Cano Jiménez, Esteban Alberto [et al.]

Effects of omalizumab in Aspergillus-associated airway disease.

2011- Parra Arrondo, Antonio; Pérez de Llano, Luis

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry

2013- Pérez de Llano, Luis

El óxido nítrico (NO) en el manejo del asma

2012- Pérez de Llano, Luis

Electrocardiogram score predicts severity of pulmonary embolism in hemodynamically stable patients.

2011- González Juanatey, Carlos; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Vázquez Caruncho, Manuel; [et al.]

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome

2012- Testa Fernández, Ana; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; López González, María Jesus; [et al.]

Hospital Epidemics Tracker (HEpiTracker): Description and Pilot Study of a Mobile App to Track COVID-19 in Hospital Workers

2020- Soriano, J. B.; Fernandez, E.; de Astorza, A.; Pérez de Llano, Luis; Fernández Villar, José Alberto; [et al.]

Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism

2011- González Juanatey, Carlos; Testa Fernández, Ana; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; [et al.]

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism.

2012- González Juanatey, Carlos; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Vázquez Caruncho, Manuel [et al.]

Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: A meta-analysis of 5 randomized trials in non-cancer and cancer patients.

2012- Pérez de Llano, Luis

Neumonía necrotizante por Finegoldia magna.

2011- Pérez de Llano, Luis; Pita Carretero, Julia; Sedano Gómez, Gianina Emily

Normativa sobre asma grave no controlada

2015- Pérez de Llano, Luis

Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches

2012- Pérez de Llano, Luis

Presentación e resultados do programa tutelado de formación en espirometrías para profesionais de atención primaria na rede sergas

2011- Pérez de Llano, Luis; Rodriguez Ledo, Pilar

Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure

2015- Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; Sanjuan López, María del Pilar; Cano Jiménez, Esteban Alberto; [et al.]

Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension

2014- González Juanatey, Carlos; Testa Fernández, Ana; Castro Añon, Olalla; Golpe Gómez, Rafael; Pérez de Llano, Luis; [et al.]

Repositorio digital RUNA

Navegar por autor "Pérez de Llano, Luis"

Asma corticodependiente: nuestra experiencia clínica ﻿

Central thromboembolism as a predictor of right ventricle dysfunction in hemodynamically stable pulmonary embolism ﻿

Clinical differences between patients with COPD due to biomass smoke or tobacco ﻿

Cost-effectiveness of asthma management in a hospital-based adult asthma clinic in Spain ﻿

Distribución de fenotipos clínicos en pacientes con enfermedad pulmonar obstructiva crónica por humo de biomasa y por tabaco ﻿

Effects of omalizumab in Aspergillus-associated airway disease. ﻿

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry ﻿

El óxido nítrico (NO) en el manejo del asma ﻿

Electrocardiogram score predicts severity of pulmonary embolism in hemodynamically stable patients. ﻿

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome ﻿

Hospital Epidemics Tracker (HEpiTracker): Description and Pilot Study of a Mobile App to Track COVID-19 in Hospital Workers ﻿

Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism ﻿

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism. ﻿

Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: A meta-analysis of 5 randomized trials in non-cancer and cancer patients. ﻿

Neumonía necrotizante por Finegoldia magna. ﻿

Normativa sobre asma grave no controlada ﻿

Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches ﻿

Presentación e resultados do programa tutelado de formación en espirometrías para profesionais de atención primaria na rede sergas ﻿

Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure ﻿

Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension ﻿

Asma corticodependiente: nuestra experiencia clínica

Central thromboembolism as a predictor of right ventricle dysfunction in hemodynamically stable pulmonary embolism

Clinical differences between patients with COPD due to biomass smoke or tobacco

Cost-effectiveness of asthma management in a hospital-based adult asthma clinic in Spain

Distribución de fenotipos clínicos en pacientes con enfermedad pulmonar obstructiva crónica por humo de biomasa y por tabaco

Effects of omalizumab in Aspergillus-associated airway disease.

Effects of omalizumab in non-atopic asthma: results from a Spanish multicenter registry

El óxido nítrico (NO) en el manejo del asma

Electrocardiogram score predicts severity of pulmonary embolism in hemodynamically stable patients.

Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilation syndrome

Hospital Epidemics Tracker (HEpiTracker): Description and Pilot Study of a Mobile App to Track COVID-19 in Hospital Workers

Long-term clinical outcome of patients with persistent right ventricle dysfunction or pulmonary hypertension after acute pulmonary embolism

Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6 months after acute pulmonary embolism.

Long-term treatment of venous thromboembolism with tinzaparin compared to vitamin K antagonists: A meta-analysis of 5 randomized trials in non-cancer and cancer patients.

Neumonía necrotizante por Finegoldia magna.

Normativa sobre asma grave no controlada

Omalizumab therapy in severe asthma: Experience from the Spanish registry - Some new approaches

Presentación e resultados do programa tutelado de formación en espirometrías para profesionais de atención primaria na rede sergas

Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure

Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension